News

Outstanding Achievement in Healthcare Supply Chain Recognized

Outstanding Achievement in Healthcare Supply Chain Recognized

ECRI Celebrates Excellence in Healthcare Supply Chain

Twelve U.S. health systems honored for superior supply chain practices

ECRI, a leading nonprofit organization focused on patient safety, has unveiled the winners of its prestigious 2025 Healthcare Supply Chain Excellence Award. This annual recognition highlights outstanding healthcare organizations in the U.S. that exemplify excellence in managing their supply chain while integrating best practice solutions.

According to Tim Browne, Vice President of Supply Chain Solutions at ECRI, the awardees this year demonstrate that supply chain excellence transcends mere cost reduction. "It’s about collaborative efforts, standardization, and making smarter decisions," Browne emphasized. The award-winning organizations showcased their strategies for consolidating vendors, implementing evidence-based product selection to minimize infection risks, and leveraging benchmarking to achieve impressive financial savings.

The following organizations have been recognized as winners of the ECRI 2025 Healthcare Supply Chain Excellence Award:

  • Broward Health
  • Chesapeake Regional Medical Center
  • The Ohio State University Wexner Medical Center
  • Pomona Valley Hospital Medical Center
  • The Queen's Health Systems
  • Stanford Medicine Supply Chain
  • United Health Services Hospitals, Inc.
  • University Hospital
  • UChicago Medicine
  • University of Missouri Health Care
  • Nicklaus Children's Health System
  • VCU Health

Now in its fourteenth year, the Healthcare Supply Chain Excellence Award recognizes ECRI clients who effectively use their supply chain services throughout the procurement lifecycle. This recognition encompasses budgeting, benchmarking, technology assessment, and strategic development. Throughout the selection process, ECRI evaluated the candidates' management strategies of capital medical devices and supplies for 2025, assessing their market analytics efforts.

Stuart Morris-Hipkins, Chief Solutions Officer at ECRI, noted that the honorees illustrate how strategic supply chain management is crucial to supporting patient care. "These organizations have proved that making data-driven decisions can yield millions in savings, allowing clinical teams to prioritize what truly matters – their patients. It’s a privilege to recognize their innovation and leadership in this vital area," he stated.

In fact, ECRI clients have identified over $13 billion in savings opportunities annually, utilizing a combination of capital and supply data. Over the past year, ECRI has thoroughly analyzed nearly $86 billion in capital and supply spending. The ECRI group comprises more than 4,000 hospitals, health systems, surgical centers, and medical groups across the United States involved in their strategic sourcing and supply chain programs.

To facilitate better patient outcomes while minimizing clinical spending, ECRI offers integrated technology decision support tools tailored for healthcare organizations, regardless of size or setting. For further inquiries, contact ECRI at (610) 825-6000, ext. 5891.

About ECRI

ECRI stands as an independent, nonprofit authority dedicated to improving the safety, quality, and cost-effectiveness of healthcare practices globally. With a commitment to technology evaluation and safety, ECRI is highly regarded by healthcare professionals and organizations for over fifty-five years. Renowned for its integrity and thoroughness, ECRI operates independently and adheres to strict conflict-of-interest rules. As the only global entity conducting independent medical device evaluations, ECRI also possesses laboratories in North America and the Asia Pacific region. The organization is recognized as an Evidence-Based Practice Center by the U.S. Agency for Healthcare Research and Quality and holds designation as a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services. ECRI expanded its influence by acquiring The Institute for Safe Medication Practices in 2020 to combat medication errors and acquired The Just Culture Company in 2024 to enhance healthcare workplace cultures, positioning itself among the largest healthcare quality and safety organizations worldwide.

Frequently Asked Questions

What is the ECRI Healthcare Supply Chain Excellence Award?

The ECRI Healthcare Supply Chain Excellence Award recognizes U.S. healthcare organizations that demonstrate exceptional supply chain management and best practices.

How are the award winners chosen?

winners are selected based on their effective utilization of supply chain services, budgeting, market analytics, and overall spend management of capital medical devices and supplies.

What does ECRI do?

ECRI is a nonprofit organization focused on improving patient safety and healthcare quality by conducting evaluations and assessments of medical technologies and practices.

Why is supply chain management important in healthcare?

Effective supply chain management is crucial as it directly impacts patient care, operational efficiency, and cost reduction within healthcare organizations.

How can organizations contact ECRI for support?

Healthcare organizations can reach ECRI by calling (610) 825-6000, ext. 5891 for assistance with their supply chain needs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 25

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 16

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 20

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 14

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 20

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 18

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 20

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Claim Losses As Telix Pharmaceuticals Faces Lawsuit

Updated Category News Views 177

Understanding the Class Action Against Telix Pharmaceuticals In recent developments, investors in Telix Pharmaceuticals Limited are facing significant challenges. The recognized law firm Bronstein, Gewirtz & Grossman, LLC has announced the filing of a class action lawsuit against the company (NASDAQ: TLX) due to substantial investor losses. This lawsuit directly affects...

Continue Reading
Brookfield Business Partners Achieves Record Stock Performance

Updated Category News Views 181

Brookfield Business Partners LP (NYSE: BBU) marked a significant milestone back in 2024 when its stock climbed to an impressive 52-week high of $23.78. This surge wasn't just random luck; it was a testament to the company's robust growth trajectory over the past year, showcasing an eye-popping increase of 52.8% in stock value. Investor Confidence: The Pulse Behind Stock...

Continue Reading
Financial Institutions, Inc. Boosts Dividend to Support Growth

Updated Category News Views 71

Financial Institutions, Inc. Declares Increased Dividend for Shareholders Financial Institutions, Inc. (NASDAQ: FISI), the parent company of Five Star Bank and Courier Capital, has announced an increase in its quarterly cash dividend. This decision reflects the company's sustained commitment to generating long-term value for its shareholders. Details of the Dividend...

Continue Reading
Pea Protein Market Poised for Rapid Growth: Key Drivers Ahead

Updated Category News Views 131

Exploring the Future of the Pea Protein Market The global pea protein market is on the brink of remarkable expansion, set to grow from USD 2.1 billion in 2024 to an impressive USD 3.7 billion by 2029. With a compound annual growth rate (CAGR) of 12.0%, this growth signals a significant shift in consumer preferences aligning towards health, wellness, and sustainability....

Continue Reading
The Unstoppable Rise of Netflix: A Stock to Watch

Updated Category News Views 166

Netflix's Remarkable Stock Journey It may sound surprising that a stock can still be considered irresistible after a staggering 350% increase, especially when it recently reached a new high. However, it’s hard not to feel optimistic about Netflix, Inc (NASDAQ: NFLX). This company, which once experienced a dramatic drop of 80% in its stock value just two years ago, has...

Continue Reading